As many know, February was American Heart Month. First recognized in 1964, Heart Month has gone on to serve as a reminder to Americans how important heart health is to themselves, their families, and their friends. It’s an important reminder too – heart disease is the #1 killer of men and women in the U.S. and claims nearly 18 million lives globally each year.
For me though, every month is heart month. I’ve built my career on it. Starting as an undergraduate at Cornell University in Materials Science and Engineering, I pursued a co-op experience working on total artificial hearts and found my passion. From that point, I knew I wanted to find new and innovative ways to use technology to fight and treat heart disease. While advances have been made, current methods need to be improved because thousands of people are still dying every day. That has to change.
That’s why I was excited about the opportunity to join the Scientific Advisory Board of BIOLIFE4D. This is a company that is pursuing a technology with tremendous potential, as well as a team of scientists and medical professionalswhose expertise in their fields is second to none. The possible applications for the technology are so exciting – the end goal of course being a 3D printed heart viable for human transplant.
But we’re also going to be able to positively affect many lives along the way as we reach certain milestones, like the creation of a cardiac patch that can be used to replace the function of a damaged area of the heart. We also hope to print miniature versions of the human heart, which can potentially replace animal models and accelerate the development of new drugs, and to produce heart valves, which are replaced via surgery more than 90,000 times a year in the U.S. alone.
One in three deaths around the world are due to heart disease, and together we have an opportunity to save those lives. That’s why I joined BIOLIFE4D.